Prince Pharmaceutical Co., Ltd. (TPEX:6935)
27.55
-1.00 (-3.50%)
Mar 9, 2026, 12:31 PM CST
Prince Pharmaceutical Revenue
Prince Pharmaceutical had revenue of 448.06M TWD in the half year ending June 30, 2025, with 25.86% growth. This brings the company's revenue in the last twelve months to 798.27M, up 8.29% year-over-year. In the year 2024, Prince Pharmaceutical had annual revenue of 690.03M, down -8.40%.
Revenue (ttm)
798.27M
Revenue Growth
+8.29%
P/S Ratio
1.26
Revenue / Employee
3.80M
Employees
210
Market Cap
1.01B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mediera | 229.85M |
| Original BioMedicals | 381.00K |
| Anxo Pharmaceutical | 883.22M |
| Excelsior Biopharma | 898.26M |
| DV Biomed | 712.61M |
| Winston Medical Supply | 724.35M |
| Bioray Biotech | 230.06M |
| General Biologicals | 251.38M |